A kind of method of multiphase duplex continuous production and preparation of vildagliptin
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHINA MEHECO SANYANG PHARMA CO LTD
- Publication Date
- 2022-07-19
Abstract
Description
technical field
[0001] The present invention relates to the field of preparation methods of vildagliptin. More specifically, the present invention relates to a method for preparing vildagliptin by multiphase duplex continuous production. Background technique
[0002] The clinical drug vildagliptin is another orally administered dipeptidyl peptidase-IV (DPP-IV) inhibitor after sitagliptin. , was approved for marketing in the European Union in 2008 for the treatment of type 2 diabetes. Vildagliptin is a selective, competitive and reversible DPP24 inhibitor.
[0003] But in general, the reaction route for synthesizing vildagliptin is long, the reaction is cumbersome, the reaction is carried out under two-phase conditions, and the production equipment is required to be high, so the energy consumption is large, the yield is low, the reaction time is long, and the follow-up treatment It is complicated and has high operating conditions, which is not conducive to the realization ...